ArticleParkinsonism & related disorders2025

Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study.

William Barbosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.